- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06329011
Combining Transcranial Direct Current Stimulation With Intermittent Oral to Esophageal Tube for Stroke-related Dysphagia
Combining Transcranial Direct Current Stimulation With Intermittent Oral to Esophageal Tube for Stroke-related Dysphagia Management: Double Blind Randomized Controlled Study
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lavie Ce
- Phone Number: 15333866454
- Email: zengxizdyfy@126.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Meet the diagnostic criteria for ischemic stroke confirmed by MRI or CT;
- Age > 18 years;
- First-time stroke;
- Swallowing disorder confirmed by swallowing contrast study or flexible endoscopic evaluation of swallowing;
- Requires enteral nutrition support;
- Stable vital signs, no severe cognitive impairment or aphasia, able to cooperate with treatment;
- Transferred to the rehabilitation department within fifteen days of onset;
- Stable vital signs.
Exclusion Criteria:
- Presence of contraindications for invasive oral endoscopy;
- Concurrent presence of other neurodegenerative diseases that may cause swallowing disorders, such as neurodegenerative diseases;
- Concurrent presence of other neurological disorders;
- Tracheostomized patients;
- Concurrent liver, kidney failure, tumor, or hematological disorders;
- Pregnancy;
- Presence of contraindications for transcranial direct current stimulation, such as epilepsy, cerebral edema;
- Recent use of centrally acting drugs that interfere with the effects of transcranial direct current stimulation, such as carbamazepine, phenytoin, valproic acid, etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Comprehensive rehabilitation+Intermittent Oro-esophageal Tube+Transcranial stimulation
The patients are randomly assigned to either the experimental group or the placebo group.
All patients receive routine rehabilitation therapy and swallowing rehabilitation training, along with enteral nutrition support using Intermittent Oro-esophageal Tube.
In addition to these interventions, patients in the experimental group receive transcranial direct current stimulation, while the instruments used for patients in the placebo group only illuminate an indicator light without any actual effect.
|
All patients are given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water.
During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall.
The distance from the incisors to the head part of the tube should be between 22-25 cm.
However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly.
After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation.
Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
In this study, transcranial direct current stimulation is performed using a battery-powered constant current stimulator.
This device delivers the current through two electrodes immersed in saline solution.
Specifically, a 50mm*50mm anodal electrode pad is placed at the center of the healthy side swallowing sensory-motor cortex of the patient.
According to the positioning method of the international 10-20 electrode system, the swallowing sensory-motor cortex of the left brain is located at the midpoint between C3 and T3, while that of the right brain is located at the midpoint between C4 and T4.
The cathode is placed on the opposite shoulder, using a current of 1mA, once a day, for 20 minutes each time, and 5 days a week.
The instruments used for placebo patients will not have any actual effect.
Including: Basic treatment, including corresponding control of risk factors and education on healthy lifestyles. Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training. Pulmonary function training, including standing training, cough training, and diaphragm muscle training. |
Placebo Comparator: Comprehensive rehabilitation+Intermittent Oro-esophageal Tube
The patients are randomly assigned to either the experimental group or the placebo group.
All patients receive routine rehabilitation therapy and swallowing rehabilitation training, along with enteral nutrition support using Intermittent Oro-esophageal Tube.
In addition to these interventions, patients in the experimental group receive transcranial direct current stimulation, while the instruments used for patients in the placebo group only illuminate an indicator light without any actual effect.
|
All patients are given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water.
During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall.
The distance from the incisors to the head part of the tube should be between 22-25 cm.
However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly.
After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation.
Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Including: Basic treatment, including corresponding control of risk factors and education on healthy lifestyles. Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training. Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
The Transcranial direct current stimulation will be performed without being turned on.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Penetration Aspiration Scale
Time Frame: day 1 and day 15
|
Penetration-Aspiration Scale is used to measure swallowing safety, which is also the primary outcome of this study.
Before and after treatment, patients are required to undergo a swallow study to complete the assessment.
This scale evaluates the patient's swallowing function level and aspiration risk by assessing leakage and aspiration during the patient's swallowing process.
The scale ranges between level 1 and level 8, with higher levels indicating poorer swallowing function and lower swallowing safety (worse outcomes).
|
day 1 and day 15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight
Time Frame: day 1 and day 15
|
Body weight measurement of the infants was conducted by the same nurse according to the relevant standards.
|
day 1 and day 15
|
Functional Oral Intake Scale
Time Frame: day 1 and day 15
|
During Dysphagia-Functional Oral Intake Scale assessment, evaluators engage in communication with the patient, conduct observations, and make records to assess the patient's oral intake ability.
The Functional Oral Intake Scale assessment form includes seven levels of scoring, ranging from level 1 to level 7, indicating a progressive improvement in the patient's oral intake ability.
In general, the result below level 6 indicates unsafe for oral intake while level 6 and above indicates that eating via mouth can be safely conducted.
|
day 1 and day 15
|
Swallowing Quality of Life Questionnaire
Time Frame: day 1 and day 15
|
The Swallowing Quality of Life Questionnaire (SWAL-QOL) is used to evaluate the impact of swallowing function on patients' quality of life.
The questionnaire consists of 44 questions related to swallowing function and quality of life.
Each question is answered using a 5-point rating scale.
In this study, the final score is converted into a percentage.
The higher scores indicate the better quality of life.
|
day 1 and day 15
|
Patient Health Questionnaire-9
Time Frame: day 1 and day 15
|
To assess the patients' depression levels, a questionnaire is used.
The questionnaire consists of 9 questions related to depressive symptoms, and each question is answered using a 4-point rating scale.
The total score ranges from 0 to 27, with higher scores indicating a greater tendency towards depression.
|
day 1 and day 15
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Nieto Luis, Site Coordinator of United Medical Group located in Miami
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TDC+IOE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Intermittent Oro-esophageal Tube Feeding
-
Copka SonpashanNot yet recruitingCerebral Small Vessel Diseases
-
Copka SonpashanNot yet recruitingPierre Robin Syndrome
-
Copka SonpashanNot yet recruitingTraumatic Brain Injury
-
MuhammadCompleted
-
Zeng ChanghaoRecruiting
-
Zeng ChanghaoRecruiting
-
Zeng ChanghaoTerminatedTraumatic Brain InjuryChina
-
Zeng ChanghaoWithdrawnTraumatic Brain InjuryChina
-
Copka SonpashanNot yet recruiting
-
Ahmadu Bello University Teaching HospitalNot yet recruitingCerebrovascular Accident